Key result
Propranolol did not significantly alter plasma norepinephrine elevation during hypotension (control: 0.22-0.74 ng/ml; short-term: 0.30-0.79 ng/ml; long-term: 0.24-0.68 ng/ml).
Why the study?
Does propranolol reduce plasma norepinephrine release during sodium nitroprusside-induced hypotension in normal subjects?
Does propranolol reduce plasma norepinephrine release during sodium nitroprusside-induced hypotension in normal subjects?
Propranolol does not appear to significantly modify sympathetic activity via a nervous system effect during induced hypotension.
Answers are grounded in this paper and cite their sources.
Does not support propranolol to blunt norepinephrine release during hypotension; leaves open effects in patients with cardiovascular disease.
The possibility of an action of propranolol which reduces traffic in the sympathetic nervous system and/or reduces release of norepinephrine at sympathetic nerve endings has been investigated in normal subjects. Plasma norephinephrine was measured in resting supine subjects before and during infusions of sodium nitroprusside which reduced the systolic blood pressure by approximately 10 and later by 20 mm Hg. In 5 subjects these observations were repeated 2 hr after a single 200-mg oral dose of propranolol and in 3 they were repeated after 2 to 8 wk of propranolol 320 mg twice daily. In the control experiments, plasma norepinephrine increased from 0.22 up to 0.74 ng/ml when the blood pressure was reduced by 17/15 mm Hg. Corresponding figures 2 hr after 200 mg propranolol were an increase of plasma norepinephrine from 0.30 or 0.79 ng/ml with a reduction of blood pressure of 19/15 mm Hg. After long-term treatment with 640 mg propranolol daily, a similar reduction of pressure with sodium nitroprusside increased plasma norepinephrine from 0.24 to 0.68 ng/ml. There was no significant alteration in the elevation of plasma norepinephrine following blood pressure reduction with nitroprusside after either short- or long-term treatment with propranolol. These experiments do not suggest a significant role for a nervous system effect of propranolol in modifying sympathetic activity.
No takes yet. Share an insight, caveat, or question.
Dean et al. (1980) studied Healthy (normal subjects) (n=8). Propranolol vs. Baseline (no propranolol) was evaluated on Plasma norepinephrine elevation following blood pressure reduction. Propranolol did not significantly alter plasma norepinephrine elevation during hypotension (control: 0.22-0.74 ng/ml; short-term: 0.30-0.79 ng/ml; long-term: 0.24-0.68 ng/ml).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: